Insider acquisitions
Explore purchases, stock awards, gifts, exercises, and conversions. These records cover acquisitions only; sales are not included.
Transaction timeline & trade size
Choose a reporting owner, transaction period, and security. Open any point for the filing.
Aug 18, 2025 – Oct 21, 2025 · Transaction dates · Current page sample
Reported transaction sizes · security units
MBX Biosciences, Inc. · Common Stock · Purchase (code P) · Non-derivative · Not reported
Swipe the chart to see the full date range. Exact records are available in the table below.
1 transaction plotted for one security and transaction type. 0 have no reported quantity. A value chart requires a stated currency. Individual reported values remain visible in the table.
50 dated transactions in this page sample · 48 reporting owners.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type | Quantity | Price | Reference value | Currency |
|---|---|---|---|---|---|---|---|
| Oct 20, 2025 | MBX Biosciences, Inc.Common Stock | Hawryluk P. Kent (President & CEO · Director) | Purchase | 20,000 | 13.6395 | 272,790 | Not reported |
| Oct 20, 2025 | TransDigm Group INCCommon Stock | Reiss Joel (Co-Chief Operating Officer) | Exercise / conversion | 3,000 | 284.97 | 854,910 | Not reported |
| Oct 20, 2025 | Corbus Pharmaceuticals Holdings, Inc.Common Stock, par value $0.0001 per share | Altmeyer Anne (Director) | Exercise / conversion | 1,060 | 4.8 | 5,088 | Not reported |
| Oct 20, 2025 | CSX CORPCommon Stock | ANGEL STEPHEN F (President & CEO · Director) | Purchase | 55,000 | 36.87 | 2,027,850 | Not reported |
| Oct 21, 2025 | PROSPERITY BANCSHARES INCCommon Stock | Davenport J. Mays (EVP/Director of Corp Strategy) | Stock award | 10,000 | 0 | 0 | Not reported |
| Oct 21, 2025 | PROSPERITY BANCSHARES INCCommon Stock | Hanigan Kevin J (President & COO · Director) | Stock award | 30,000 | 0 | 0 | Not reported |
| Oct 19, 2025 | Vivid Seats Inc.Class A Common Stock | Dixon Craig A. (Director) | Exercise / conversion | 245 | Not reported | Not reported | Not reported |
| Oct 19, 2025 | Vivid Seats Inc.Class A Common Stock | Boehly Todd L (Director · 10% owner) | Exercise / conversion | 245 | Not reported | Not reported | Not reported |
| Oct 19, 2025 | Vivid Seats Inc.Class A Common Stock | ANDERSON MARK M. (Director) | Exercise / conversion | 245 | Not reported | Not reported | Not reported |
| Oct 19, 2025 | Vivid Seats Inc.Class A Common Stock | Bakal Riva (Chief Supply/Customer Officer) | Exercise / conversion | 193 | Not reported | Not reported | Not reported |
| Oct 19, 2025 | Vivid Seats Inc.Class A Common Stock | Masino Julie D. (Director) | Exercise / conversion | 245 | Not reported | Not reported | Not reported |
| Oct 19, 2025 | Vivid Seats Inc.Class A Common Stock | Donnini David (Director) | Exercise / conversion | 245 | Not reported | Not reported | Not reported |
| Oct 19, 2025 | Vivid Seats Inc.Class A Common Stock | Pickus Edward (Chief Accounting Officer) | Exercise / conversion | 91 | Not reported | Not reported | Not reported |
| Oct 19, 2025 | Vivid Seats Inc.Class A Common Stock | Fey Lawrence (Chief Financial Officer) | Exercise / conversion | 625 | Not reported | Not reported | Not reported |
| Oct 19, 2025 | Vivid Seats Inc.Class A Common Stock | Chia Stanley (Chief Executive Officer · Director) | Exercise / conversion | 782 | Not reported | Not reported | Not reported |
| Oct 19, 2025 | Vivid Seats Inc.Class A Common Stock | DeFlorio Jane E. (Director) | Exercise / conversion | 245 | Not reported | Not reported | Not reported |
| Oct 14, 2025 | ATOSSA THERAPEUTICS, INC.Stock Option (right to buy) | Daniel Mark James (Chief Financial Officer) | Stock award | 578,000 | 0 | 0 | Not reported |
| Oct 20, 2025 | FATE THERAPEUTICS INCStock Option (Right to Buy) | Adawi Kamal (Chief Financial Officer) | Stock award | 375,000 | 0 | 0 | Not reported |
| Oct 20, 2025 | FATE THERAPEUTICS INCCommon Stock | Adawi Kamal (Chief Financial Officer) | Stock award | 75,000 | 0 | 0 | Not reported |
| Oct 18, 2025 | Solid Biosciences Inc.Common Stock | Brooks Gabriel (Chief Medical Officer) | Exercise / conversion | 9,750 | Not reported | Not reported | Not reported |
| Oct 17, 2025 | AGENUS INCCommon Stock | ARMEN GARO H (See Remarks · Director) | Stock award | 4,216 | 3.88 | 16,358.08 | Not reported |
| Oct 17, 2025 | Sphere Entertainment Co.Restricted Stock Units | Dolan Ryan Thomas (Director) | Stock award | 716 | 0 | 0 | Not reported |
| Oct 19, 2025 | HERON THERAPEUTICS, INC. /DE/Common Stock | Forbes William P (EVP, Chief Development Officer) | Exercise / conversion | 3,874 | Not reported | Not reported | Not reported |
| Oct 19, 2025 | HERON THERAPEUTICS, INC. /DE/Common Stock | Duarte Ira (EVP, Chief Financial Officer) | Exercise / conversion | 3,874 | Not reported | Not reported | Not reported |
| Oct 19, 2025 | HERON THERAPEUTICS, INC. /DE/Common Stock | Collard Craig A (Chief Executive Officer · Director) | Exercise / conversion | 13,797 | Not reported | Not reported | Not reported |
| Oct 17, 2025 | IGC Pharma, Inc.Options | Moran James P (Director) | Stock award | 500,000 | 0 | 0 | Not reported |
| Oct 17, 2025 | IGC Pharma, Inc.Options | LIERMAN TERRY L (Director) | Stock award | 500,000 | 0 | 0 | Not reported |
| Oct 17, 2025 | IGC Pharma, Inc.Options | GRIMALDI CLAUDIA (PFO · Director) | Stock award | 500,000 | 0 | 0 | Not reported |
| Oct 17, 2025 | IGC Pharma, Inc.Options | GRIMALDI CLAUDIA (PFO · Director) | Stock award | 1,000,000 | 0 | 0 | Not reported |
| Oct 17, 2025 | SCYNEXIS INCCommon Stock | Angulo Gonzalez David (Chief Executive Officer · Director) | Stock award | 32,500 | 0.76 | 24,700 | Not reported |
| Oct 1, 2025 | NABORS INDUSTRIES LTDCommon Stock | Rodriguez Rodriguez Miguel Angel (CHIEF FINANCIAL OFFICER) | Stock award | 4,807 | 0 | 0 | Not reported |
| Oct 19, 2025 | Seagate Technology Holdings plcOrdinary Shares | Arumugavelu Shankar (Director) | Exercise / conversion | 2,693 | 0 | 0 | Not reported |
| Oct 19, 2025 | Seagate Technology Holdings plcOrdinary Shares | BRUNER JUDY (Director) | Exercise / conversion | 2,693 | 0 | 0 | Not reported |
| Oct 19, 2025 | Seagate Technology Holdings plcOrdinary Shares | CANNON MICHAEL R (Director) | Exercise / conversion | 3,427 | 0 | 0 | Not reported |
| Oct 19, 2025 | Seagate Technology Holdings plcOrdinary Shares | BHATT PRAT (Director) | Exercise / conversion | 2,693 | 0 | 0 | Not reported |
| Oct 19, 2025 | Seagate Technology Holdings plcOrdinary Shares | Haggart Dylan G. (Director) | Exercise / conversion | 2,693 | 0 | 0 | Not reported |
| Oct 19, 2025 | Seagate Technology Holdings plcOrdinary Shares | Tilenius Stephanie (Director) | Exercise / conversion | 2,693 | 0 | 0 | Not reported |
| Oct 19, 2025 | Seagate Technology Holdings plcOrdinary Shares | CLEMMER RICHARD L (Director) | Exercise / conversion | 2,693 | 0 | 0 | Not reported |
| Oct 19, 2025 | Seagate Technology Holdings plcOrdinary Shares | Conyers Yolanda Lee (Director) | Exercise / conversion | 2,693 | 0 | 0 | Not reported |
| Oct 19, 2025 | Seagate Technology Holdings plcOrdinary Shares | Geldmacher Jay L (Director) | Exercise / conversion | 2,693 | 0 | 0 | Not reported |
| Oct 19, 2025 | Seagate Technology Holdings plcOrdinary Shares | Adams Mark (Director) | Exercise / conversion | 2,693 | 0 | 0 | Not reported |
| Oct 20, 2025 | AMERICAN PUBLIC EDUCATION INCCommon Stock, par value $.01 | Codispoti Edward H (EVP & Chief Financial Officer) | Stock award | 8,477 | 0 | 0 | Not reported |
| Oct 20, 2025 | Salesforce, Inc.Common Stock | Benioff Marc (Chair and CEO · Director) | Exercise / conversion | 2,250 | 161.5 | 363,375 | Not reported |
| Oct 21, 2025 | PHIBRO ANIMAL HEALTH CORPClass A Common Stock | BENDHEIM JACK (President and CEO · Director · 10% owner) · BFI Co., LLC (10% owner) | Conversion | 50,000 | 0 | 0 | Not reported |
| Oct 18, 2025 | BlueLinx Holdings Inc.Common Stock | DeBrock Kimberly Ann (VP & Chief Accounting Officer) | Exercise / conversion | 232 | Not reported | Not reported | Not reported |
| Oct 21, 2025 | CYTOKINETICS INCCommon Stock | Malik Fady Ibraham (EVP Research & Development) | Exercise / conversion | 2,105 | 10.6 | 22,313 | Not reported |
| Oct 15, 2025 | CYTOKINETICS INCCommon Stock | WIERENGA WENDELL (Director) | Stock award | 99 | 62.8 | 6,217.2 | Not reported |
| Oct 17, 2025 | EAGLE CAPITAL GROWTH FUND, INC.Common Stock | SIMS LUKE E (President & CEO · Director) | Purchase | 2,000 | 10.75 | 21,500 | Not reported |
| Aug 18, 2025 | EAGLE CAPITAL GROWTH FUND, INC.Common Stock | SIMS LUKE E (President & CEO · Director) | Other acquisition | 975 | 10.11 | 9,857.25 | Not reported |
| Oct 17, 2025 | NRC HEALTHDirector Stock Option (Right to Buy) | NUNNELLY JOHN N (Director) | Stock award | 22,625 | 0 | 0 | Not reported |
Only transactions on this page are shown. Preset date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Transaction details
Reporting owners, quantities, prices, and source filings.
| Filed / transacted | Company | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|---|
| Transacted: | MBX Biosciences, Inc.MBX · company listings | Hawryluk P. KentPresident & CEO · Director | PurchaseCommon StockNon-derivative security · Code P | 20,000 | 13.6395 *Value: 272,790Not reported | View ↗ |
| Transacted: | TransDigm Group INCTDG · company listings | Reiss JoelCo-Chief Operating Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 3,000 | 284.97Value: 854,910Not reported | View ↗ |
| Transacted: | Corbus Pharmaceuticals Holdings, Inc.CRBP · company listings | Altmeyer AnneDirector | Exercise / conversionCommon Stock, par value $0.0001 per shareNon-derivative security · Code M | 1,060 | 4.8Value: 5,088Not reported | View ↗ |
| Transacted: | CSX CORPCSX · company listings | ANGEL STEPHEN FPresident & CEO · Director | PurchaseCommon StockNon-derivative security · Code P | 55,000 | 36.87 *Value: 2,027,850Not reported | View ↗ |
| Transacted: | PROSPERITY BANCSHARES INCPB · company listings | Davenport J. MaysEVP/Director of Corp Strategy | Stock awardCommon StockNon-derivative security · Code A | 10,000 | 0Value: 0Not reported | View ↗ |
| Transacted: | PROSPERITY BANCSHARES INCPB · company listings | Hanigan Kevin JPresident & COO · Director | Stock awardCommon StockNon-derivative security · Code A | 30,000 | 0Value: 0Not reported | View ↗ |
| Transacted: | Vivid Seats Inc.SEAT · company listings | Dixon Craig A.Director | Exercise / conversionClass A Common StockNon-derivative security · Code M | 245 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | Vivid Seats Inc.SEAT · company listings | Boehly Todd LDirector · 10% owner | Exercise / conversionClass A Common StockNon-derivative security · Code M | 245 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | Vivid Seats Inc.SEAT · company listings | ANDERSON MARK M.Director | Exercise / conversionClass A Common StockNon-derivative security · Code M | 245 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | Vivid Seats Inc.SEAT · company listings | Bakal RivaChief Supply/Customer Officer | Exercise / conversionClass A Common StockNon-derivative security · Code M | 193 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | Vivid Seats Inc.SEAT · company listings | Masino Julie D.Director | Exercise / conversionClass A Common StockNon-derivative security · Code M | 245 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | Vivid Seats Inc.SEAT · company listings | Donnini DavidDirector | Exercise / conversionClass A Common StockNon-derivative security · Code M | 245 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | Vivid Seats Inc.SEAT · company listings | Pickus EdwardChief Accounting Officer | Exercise / conversionClass A Common StockNon-derivative security · Code M | 91 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | Vivid Seats Inc.SEAT · company listings | Fey LawrenceChief Financial Officer | Exercise / conversionClass A Common StockNon-derivative security · Code M | 625 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | Vivid Seats Inc.SEAT · company listings | Chia StanleyChief Executive Officer · Director | Exercise / conversionClass A Common StockNon-derivative security · Code M | 782 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | Vivid Seats Inc.SEAT · company listings | DeFlorio Jane E.Director | Exercise / conversionClass A Common StockNon-derivative security · Code M | 245 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | ATOSSA THERAPEUTICS, INC.ATOS · company listings | Daniel Mark JamesChief Financial Officer | Stock awardStock Option (right to buy)Derivative security · Code A | 578,000 | 0Value: 0Not reported | View ↗ |
| Transacted: | FATE THERAPEUTICS INCFATE · company listings | Adawi KamalChief Financial Officer | Stock awardStock Option (Right to Buy)Derivative security · Code A | 375,000 | 0Value: 0Not reported | View ↗ |
| Transacted: | FATE THERAPEUTICS INCFATE · company listings | Adawi KamalChief Financial Officer | Stock awardCommon StockNon-derivative security · Code A | 75,000 | 0Value: 0Not reported | View ↗ |
| Transacted: | Solid Biosciences Inc.SLDB · company listings | Brooks GabrielChief Medical Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 9,750 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | AGENUS INCAGEN · company listings | ARMEN GARO HSee Remarks · Director | Stock awardCommon StockNon-derivative security · Code A | 4,216 | 3.88 *Value: 16,358.08Not reported | View ↗ |
| Transacted: | Sphere Entertainment Co.SPHR · company listings | Dolan Ryan ThomasDirector | Stock awardRestricted Stock UnitsDerivative security · Code A | 716 | 0Value: 0Not reported | View ↗ |
| Transacted: | HERON THERAPEUTICS, INC. /DE/HRTX · company listings | Forbes William PEVP, Chief Development Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 3,874 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | HERON THERAPEUTICS, INC. /DE/HRTX · company listings | Duarte IraEVP, Chief Financial Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 3,874 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | HERON THERAPEUTICS, INC. /DE/HRTX · company listings | Collard Craig AChief Executive Officer · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 13,797 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | IGC Pharma, Inc.IGC · company listings | Moran James PDirector | Stock awardOptionsDerivative security · Code A | 500,000 | 0Value: 0Not reported | View ↗ |
| Transacted: | IGC Pharma, Inc.IGC · company listings | LIERMAN TERRY LDirector | Stock awardOptionsDerivative security · Code A | 500,000 | 0Value: 0Not reported | View ↗ |
| Transacted: | IGC Pharma, Inc.IGC · company listings | GRIMALDI CLAUDIAPFO · Director | Stock awardOptionsDerivative security · Code A | 500,000 | 0Value: 0Not reported | View ↗ |
| Transacted: | IGC Pharma, Inc.IGC · company listings | GRIMALDI CLAUDIAPFO · Director | Stock awardOptionsDerivative security · Code A | 1,000,000 | 0Value: 0Not reported | View ↗ |
| Transacted: | SCYNEXIS INCSCYX · company listings | Angulo Gonzalez DavidChief Executive Officer · Director | Stock awardCommon StockNon-derivative security · Code A | 32,500 | 0.76Value: 24,700Not reported | View ↗ |
| Transacted: | NABORS INDUSTRIES LTDNBR · company listings | Rodriguez Rodriguez Miguel AngelCHIEF FINANCIAL OFFICER | Stock awardCommon StockNon-derivative security · Code A | 4,807 | 0Value: 0Not reported | View ↗ |
| Transacted: | Seagate Technology Holdings plcSTX · company listings | Arumugavelu ShankarDirector | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 2,693 | 0Value: 0Not reported | View ↗ |
| Transacted: | Seagate Technology Holdings plcSTX · company listings | BRUNER JUDYDirector | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 2,693 | 0Value: 0Not reported | View ↗ |
| Transacted: | Seagate Technology Holdings plcSTX · company listings | CANNON MICHAEL RDirector | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 3,427 | 0Value: 0Not reported | View ↗ |
| Transacted: | Seagate Technology Holdings plcSTX · company listings | BHATT PRATDirector | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 2,693 | 0Value: 0Not reported | View ↗ |
| Transacted: | Seagate Technology Holdings plcSTX · company listings | Haggart Dylan G.Director | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 2,693 | 0Value: 0Not reported | View ↗ |
| Transacted: | Seagate Technology Holdings plcSTX · company listings | Tilenius StephanieDirector | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 2,693 | 0Value: 0Not reported | View ↗ |
| Transacted: | Seagate Technology Holdings plcSTX · company listings | CLEMMER RICHARD LDirector | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 2,693 | 0Value: 0Not reported | View ↗ |
| Transacted: | Seagate Technology Holdings plcSTX · company listings | Conyers Yolanda LeeDirector | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 2,693 | 0Value: 0Not reported | View ↗ |
| Transacted: | Seagate Technology Holdings plcSTX · company listings | Geldmacher Jay LDirector | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 2,693 | 0Value: 0Not reported | View ↗ |
| Transacted: | Seagate Technology Holdings plcSTX · company listings | Adams MarkDirector | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 2,693 | 0Value: 0Not reported | View ↗ |
| Transacted: | AMERICAN PUBLIC EDUCATION INCAPEI · company listings | Codispoti Edward HEVP & Chief Financial Officer | Stock awardCommon Stock, par value $.01Non-derivative security · Code A | 8,477 | 0Value: 0Not reported | View ↗ |
| Transacted: | Salesforce, Inc.CRM · company listings | Benioff MarcChair and CEO · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 2,250 | 161.5Value: 363,375Not reported | View ↗ |
| Transacted: | PHIBRO ANIMAL HEALTH CORPPAHC · company listings | BENDHEIM JACKPresident and CEO · Director · 10% owner BFI Co., LLC10% owner Joint filing · amounts unallocated | ConversionClass A Common StockNon-derivative security · Code C | 50,000 | 0Value: 0Not reported | View ↗ |
| Transacted: | BlueLinx Holdings Inc.BXC · company listings | DeBrock Kimberly AnnVP & Chief Accounting Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 232 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | CYTOKINETICS INCCYTK · company listings | Malik Fady IbrahamEVP Research & Development | Exercise / conversionCommon StockNon-derivative security · Code M | 2,105 | 10.6Value: 22,313Not reported | View ↗ |
| Transacted: | CYTOKINETICS INCCYTK · company listings | WIERENGA WENDELLDirector | Stock awardCommon StockNon-derivative security · Code A | 99 | 62.8Value: 6,217.2Not reported | View ↗ |
| Transacted: | EAGLE CAPITAL GROWTH FUND, INC.GRF · company listings | SIMS LUKE EPresident & CEO · Director | PurchaseCommon StockNon-derivative security · Code P | 2,000 | 10.75Value: 21,500Not reported | View ↗ |
| Transacted: | EAGLE CAPITAL GROWTH FUND, INC.GRF · company listings | SIMS LUKE EPresident & CEO · Director | Other acquisitionCommon StockNon-derivative security · Code L | 975 | 10.11Value: 9,857.25Not reported | View ↗ |
| Transacted: | NRC HEALTHNRC · company listings | NUNNELLY JOHN NDirector | Stock awardDirector Stock Option (Right to Buy)Derivative security · Code A | 22,625 | 0Value: 0Not reported | View ↗ |
50 transactions on this page. Filing date, newest first.
Filters use the date a filing was submitted, not the date of the transaction. Coverage is incomplete while historical records are being loaded. How we organize the data →